Best Practices for Hit-to-Lead - Case Study: MALT1 Inhibitors
European Federation for Medicinal Chemistry
0:00 / 0:00
Best Practices for Hit-to-Lead - Case Study: MALT1 Inhibitors
1 201 просмотр · 2 г. назад
European Federation for Medicinal Chemistry
1,87 тыс. подписчиков
1 201 просмотр · 2 г. назад
The Hit-to-Lead Process is a crucial part of an early drug discovery project.
This webinar highlights the strategy and key decision criteria for prioritization and subsequent optimization of chemical matter using the discovery of MALT1 Inhibitors as case study.